The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure of the nucleosome core particle at 2.8 Å resolution
Luger, K., Mäder, A. W., Richmond, R. K., Sargent, D. F., & Richmond, T. J. (1997) · Nature · doi:10.1038/38444 · Cited by 9,466
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919 · cited 1×
“In addition, class I/II HDACs have emerged as attractive targets for cancer therapy, as HDAC inhibitors have been found to have potent and specific anticancer activities in preclinical studies (Kelly et al., 2002, 2003; Marks and Jiang, 2005; Bolden et al., 2006).”
BackgroundNegative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R., Leid, M., McBurney, M. W., & Guarente, L. (2004) · Nature · doi:10.1038/nature02583 · Cited by 1,952
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Acetylation of Histones and Transcription-Related Factors
Sterner, D. E., & Berger, S. L. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.2.435-459.2000 · Cited by 1,780
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
Gregoretti, I., Lee, Y.-M., & Goodson, H. V. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.02.006 · Cited by 1,456
Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
Frye, R. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3000 · Cited by 1,409
Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction
Haigis, M. C., & Guarente, L. P. (2006) · Genes & Development · doi:10.1101/gad.1467506 · Cited by 1,295 · cited 1×
“Finally, the class III HDACs, or sirtuins, have been implicated in diverse biological processes including physiology, metabolism and longevity (Haigis and Guarente, 2006).”
BackgroundHaigis, M. C., Mostoslavsky, R., Haigis, K. M., Fahie, K., Christodoulou, D. C., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., Karow, M., Blander, G., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.057 · Cited by 1,162
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice
Cheng, H.-L., Mostoslavsky, R., Saito, S., Manis, J. P., Gu, Y., Patel, P., Bronson, R., Appella, E., Alt, F. W., & Chua, K. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934713100 · Cited by 1,095 · cited 2×
“…shown to deacetylate a-tubulin (Serrador et al., 2004), and SIRT1 has been shown to deacetylate the p53 tumor suppressor protein (Luo et al., 2001; Cheng et al., 2003) and the forkhead transcription factor (FOXO) (Brunet et al., 2004) and PPARg (peroxisome proliferator-activated receptor-g)…”
BackgroundMechanism of Human SIRT1 Activation by Resveratrol
Borra, M. T., Smith, B. C., & Denu, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501250200 · Cited by 1,065 · cited 2×
“…shown a SIRT1-dependant activation in response to resveratrol (Howitz et al., 2003; Wood et al., 2004a; Baur et al., 2006), the biochemical activation of sirtuin proteins has been a matter of debate and will require further study (Howitz et al., 2003; Borra et al., 2005; Kaeberlein et al., 2005).”
BackgroundBalasubramanyam, K., Varier, R. A., Altaf, M., Swaminathan, V., Siddappa, N. B., Ranga, U., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409024200 · Cited by 832
Sauve, A. A., Wolberger, C., Schramm, V. L., & Boeke, J. D. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133500 · Cited by 763
Substrate-specific activation of sirtuins by resveratrol
Kaeberlein, M., McDonagh, T., Heltweg, B., Hixon, J., Westman, E. A., Caldwell, S. D., Napper, A., Curtis, R., DiStefano, P. S., Fields, S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500655200 · Cited by 745
Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710 · cited 1×
“Following the report of HDLP, two different groups reported on the structure of the class I HDAC, HDAC8, bound to several different inhibitors (Somoza et al., 2004; Vannini et al., 2004).”
BackgroundHDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics
Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C. (2007) · Cell Research · doi:10.1038/sj.cr.7310149 · Cited by 678 · cited 1×
“Various small-molecule HDAC inhibitors that have shown antitumor activity in model systems have advanced into clinical trials (Lin et al., 2006; Gallinari et al., 2007), and SAHA (suberoylanilide hydroxamic acid, vorinostat) was recently shown to inhibit the growth of pancreatic cancer cells…”
BackgroundVannini, A., Volpari, C., Filocamo, G., Casavola, E. C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404603101 · Cited by 638
Kelly, W. K., Richon, V. M., O’Connor, O. A., Curley, T., MacGregor‐Cortelli, B., Tong, W. P., Klang, M. G., Schwartz, L. B., Richardson, S., Rosa, E., et al. (2003) · PubMed · Cited by 624
Hideshima, T., Bradner, J. E., Wong, J., Chauhan, D., Richardson, P., Schreiber, S. L., & Anderson, K. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503221102 · Cited by 593
Mouse Sir2 Homolog SIRT6 Is a Nuclear ADP-ribosyltransferase
Liszt, G., Ford, E., Kurtev, M., & Guarente, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413296200 · Cited by 548 · cited 1×
“Interestingly, SIRT4 and 6 have been shown to catalyse ADP ribosylation instead of deacetylation (Liszt et al., 2005; Haigis et al., 2006).”
BackgroundBalasubramanyam, K., Altaf, M., Varier, R. A., Swaminathan, V., Ravindran, A., Sadhale, P. P., & Kundu, T. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402839200 · Cited by 546
Brownell, J. E., & Allis, C. D. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80048-7 · Cited by 534
Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons
Parker, J. A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., & Néri, C. (2005) · Nature Genetics · doi:10.1038/ng1534 · Cited by 512
Sirtuins: critical regulators at the crossroads between cancer and aging
Saunders, L. R., & Verdin, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210616 · Cited by 489
Antitumor Activity of a Small-Molecule Inhibitor of Human Silent Information Regulator 2 Enzymes
Heltweg, B., Gatbonton, T., Schuler, A. D., Posakony, J., Li, H., Goehle, S., Kollipara, R., DePinho, R. A., Gu, Y., Simon, J. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3617 · Cited by 469
Avalos, J. L., Bever, K. M., & Wolberger, C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.022 · Cited by 464
Neuwald, A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01034-7 · Cited by 447
Regulation of the p300 HAT domain via a novel activation loop
Thompson, P. R., Wang, D., Wang, L., Fulco, M., Pediconi, N., Zhang, D., An, W., Ge, Q., Roeder, R. G., Wong, J., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb740 · Cited by 423
Conjunction dysfunction: CBP/p300 in human disease
Giles, R. H., Peters, D. J. M., & Breuning, M. H. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01438-3 · Cited by 403
Histone acetyltransferases: function, structure, and catalysis
Marmorstein, R., & Roth, S. Y. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00173-8 · Cited by 401
Self-citationLau, O. D., Kundu, T. K., Soccio, R. E., Ait-Si-Ali, S., Khalil, E. M., Vassilev, A., Wolffe, A. P., Nakatani, Y., Roeder, R. G., & Cole, P. A. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80452-9 · Cited by 394
Histone acetylation and disease
Timmermann, S., Lehrmann, H., Polesskaya, A., & Harel-Bellan, A. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000896 · Cited by 341
Histone chaperones, a supporting role in the limelight
Loyola, A., & Almouzni, G. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2003.09.012 · Cited by 331
Epigenetics—An Epicenter of Gene Regulation: Histones and Histone‐Modifying Enzymes
Biel, M., Wascholowski, V., & Giannis, A. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200461346 · Cited by 316
SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress
Kobayashi, Y., Furukawa-Hibi, Y., Chen, C., Horio, Y., Isobe, K., Ikeda, K., & Motoyama, N. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.16.2.237 · Cited by 313
Histone modifications: signalling receptors and potential elements of a heritable epigenetic code
Nightingale, K. P., O’Neill, L. P., & Turner, B. M. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.02.015 · Cited by 311
Chemistry of Gene Silencing: The Mechanism of NAD+-Dependent Deacetylation Reactions
Sauve, A. A., Celic, I., Avalos, J., Deng, H., Boeke, J. D., & Schramm, V. L. (2001) · Biochemistry · doi:10.1021/bi011858j · Cited by 300
p300 gene alterations in colorectal and gastric carcinomas.
Muraoka, M., Konishi, M., Kikuchi‐Yanoshita, R., Tanaka, K., Shitara, N., Chong, J., Iwama∥, T., & Miyaki, M. (1996) · PubMed · Cited by 282
Structure of Tetrahymena GCN5 bound to coenzyme A and a histone H3 peptide
Rojas, J. R., Trievel, R. C., Zhou, J., Mo, Y., Li, X., Berger, S. L., Allis, C. D., & Marmorstein, R. (1999) · Nature · doi:10.1038/43487 · Cited by 268
Self-citationStructural Basis of Inhibition of the Human NAD+-Dependent Deacetylase SIRT5 by Suramin
Schuetz, A., Min, J., Antoshenko, T., Wang, C.-L., Allali-Hassani, A., Dong, A., Loppnau, P., Vedadi, M., Bochkarev, A., Sternglanz, R., et al. (2007) · Structure · doi:10.1016/j.str.2007.02.002 · Cited by 261
Histone deacetylase inhibitors: from target to clinical trials
Kelly, W. K., O’Connor, O. A., & Marks, P. A. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.12.1695 · Cited by 253
Targeting histone deacetylase in cancer therapy
Lin, H., Chen, C., Lin, S., Weng, J., & Chen, C. (2006) · Medicinal Research Reviews · doi:10.1002/med.20056 · Cited by 241
Mechanism of Nicotinamide Inhibition and Transglycosidation by Sir2 Histone/Protein Deacetylases
Jackson, M. D., Schmidt, M. T., Oppenheimer, N. J., & Denu, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306552200 · Cited by 239
Linking histone acetylation to transcriptional regulation
Mizzen, C. A., & Allis, C. D. (1998) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050121 · Cited by 235
Tanner, K. G., Trievel, R. C., Kuo, M.-H., Howard, R. M., Berger, S. L., Allis, C. D., Marmorstein, R., & Denu, J. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18157 · Cited by 221
Self-citationSauve, A. A., & Schramm, V. L. (2003) · Biochemistry · doi:10.1021/bi034959l · Cited by 215
Jackson, M. D., & Denu, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200671200 · Cited by 212
Hat1: the emerging cellular roles of a type B histone acetyltransferase
Parthun, M. R. (2007) · Oncogene · doi:10.1038/sj.onc.1210602 · Cited by 207
HDAC6 Deacetylase Activity Links the Tubulin Cytoskeleton with Immune Synapse Organization
Serrador, J. M., Cabrero, J. R., Sancho, D., Mittelbrunn, M., Urzainqui, A., & Sánchez-Madrid, F. (2004) · Immunity · doi:10.1016/s1074-7613(04)00078-0 · Cited by 193
Zhao, K., Harshaw, R., Chai, X., & Marmorstein, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401057101 · Cited by 187
Self-citationMOZ is fused top300 in an acute monocytic leukemia with t(8;22)
Chaffanet, M., Gressin, L., Preudhomme, C., Soenen, V., Birnbaum, D., & P�busque, M.-J. (2000) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(200006)28:2<138::aid-gcc2>3.0.co;2-2 · Cited by 184
Kumagai, T., Wakimoto, N., Yin, D., Gery, S., Kawamata, N., Takai, N., Komatsu, N., Chumakov, A., Imai, Y., & Koeffler, H. P. (2007) · International Journal of Cancer · doi:10.1002/ijc.22558 · Cited by 182
Crystal structure and mechanism of histone acetylation of the yeast GCN5 transcriptional coactivator
Trievel, R. C., Rojas, J. R., Sterner, D. E., Venkataramani, R. N., Wang, L., Zhou, J., Allis, C. D., Berger, S. L., & Marmorstein, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.8931 · Cited by 181
Self-citationHistone modifying enzymes and cancer: Going beyond histones
Zhang, K., & Dent, S. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20615 · Cited by 179
Neuronal protection by sirtuins in Alzheimer's disease
Anekonda, T. S., & Reddy, P. H. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03492.x · Cited by 166
Yan, Y., Barlev, N. A., Haley, R. H., Berger, S. L., & Marmorstein, R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00116-7 · Cited by 163
Self-citationYuan, Y., Harper, S. L., Speicher, D. W., & Marmorstein, R. (2002) · Nature Structural Biology · doi:10.1038/nsb849 · Cited by 162
Self-citationStructure and function of histone acetyltransferases
Marmorstein, R. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000893 · Cited by 160
Self-citationInhibitors of Sir2: Evaluation of Splitomicin Analogues
Posakony, J., Hirao, M., Stevens, S., Simon, J. A., & Bedalov, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030473r · Cited by 160
Clements, A. M., Rojas, J. R., Trievel, R. C., Wang, L., Berger, S. L., & Marmorstein, R. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3521 · Cited by 159
Self-citationCrystal Structure of a Bacterial Class 2 Histone Deacetylase Homologue
Nielsen, T. K., Hildmann, C., Dickmanns, A., Schwienhorst, A., & Ficner, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.065 · Cited by 158
Structural Basis for the Mechanism and Regulation of Sir2 Enzymes
Avalos, J. L., Boeke, J. D., & Wolberger, C. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00082-6 · Cited by 153
Histone Deacetylase Inhibitors in Programmed Cell Death and Cancer Therapy
Marks, P. A., & Jiang, X. (2005) · Cell Cycle · doi:10.4161/cc.4.4.1564 · Cited by 142
Insights into the Sirtuin Mechanism from Ternary Complexes Containing NAD+ and Acetylated Peptide
Hoff, K. G., Avalos, J. L., Sens, K. L., & Wolberger, C. (2006) · Structure · doi:10.1016/j.str.2006.06.006 · Cited by 141
Woodcock, C. L. F. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.02.005 · Cited by 139
Catalytic Mechanism of a MYST Family Histone Acetyltransferase
Berndsen, C., Albaugh, B. N., Tan, S., & Denu, J. M. (2006) · Biochemistry · doi:10.1021/bi602513x · Cited by 136
p300/CBP-associated Factor Histone Acetyltransferase Processing of a Peptide Substrate
Lau, O. D., Courtney, A. D., Vassilev, A. P., Marzilli, L. A., Cotter, R. J., Nakatani, Y., & Cole, P. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003219200 · Cited by 120
Structure of the GCN5 histone acetyltransferase bound to a bisubstrate inhibitor
Poux, A. N., Cebrat, M., Kim, C. M., Cole, P. A., & Marmorstein, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222373899 · Cited by 112
Self-citationRegulation of higher-order chromatin structures by nucleosome-remodelling factors
Varga‐Weisz, P., & Becker, P. B. (2006) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.02.006 · Cited by 103
Sir2 Deacetylases Exhibit Nucleophilic Participation of Acetyl-Lysine in NAD+ Cleavage
Smith, B. C., & Denu, J. M. (2007) · Journal of the American Chemical Society · doi:10.1021/ja070162w · Cited by 98
Structure of Histone Deacetylases
Marmorstein, R. (2001) · Structure · doi:10.1016/s0969-2126(01)00690-6 · Cited by 97
Self-citationSolution structure of the catalytic domain of GCN5 histone acetyltransferase bound to coenzyme A
Lin, Y., Fletcher, C. M., Zhou, J., Allis, C. D., & Wagner, G. (1999) · Nature · doi:10.1038/21922 · Cited by 93
Structure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases
Marmorstein, R. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320904 · Cited by 85
Self-citationInnovative Agents in Cancer Prevention
Manson, M. M., Farmer, P. B., Gescher, A. J., & Steward, W. P. (2005) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/3-540-26980-0_17 · Cited by 82
Poux, A. N., & Marmorstein, R. (2003) · Biochemistry · doi:10.1021/bi035632n · Cited by 73
Self-citationStructural Basis for Nicotinamide Inhibition and Base Exchange in Sir2 Enzymes
Sanders, B. D., Zhao, K., Slama, J. T., & Marmorstein, R. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.022 · Cited by 68
Self-citationVarier, R. A., Swaminathan, V., Balasubramanyam, K., & Kundu, T. K. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.038 · Cited by 52
Vanommeslaeghe, K., Proft, F. D., Loverix, S., Tourwé, D. A., & Geerlings, P. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.001 · Cited by 46
TAGging the target for damage control
Yan, K. S., & Zhou, M. (2002) · Nature Structural Biology · doi:10.1038/nsb0902-638 · Cited by 44
Selective HAT Inhibitors as Mechanistic Tools for Protein Acetylation
Zheng, Y. G., Thompson, P. R., Cebrat, M., Wang, L., Devlin, M. K., Alani, R. M., & Cole, P. A. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)76012-1 · Cited by 40
Bisubstrate analogue structure?activity relationships for p300 histone acetyltransferase inhibitors
Sagar, V., Zheng, W., Thompson, P. R., & Cole, P. A. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.070 · Cited by 37
Nielsen, T. K., Hildmann, C., Riester, D., Wegener, D., Schwienhorst, A., & Ficner, R. (2007) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309107012377 · Cited by 33
Khan, A. N., & Lewis, P. N. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511482200 · Cited by 22
Moreth, K., Riester, D., Hildmann, C., Hempel, R., Wegener, D., Schober, A., & Schwienhorst, A. (2007) · Biochemical Journal · doi:10.1042/bj20061239 · Cited by 20
Insights into Structure and Function of GCN5⧸PCAF and yEsa 1 Histone Acetyltransferase Domains:
Clements, A. M., & Marmorstein, R. (2003) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(03)71041-6 · Cited by 10
Self-citation
Cited by
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012
Yang, X.-J., & Seto, E. (2007) · Oncogene · doi:10.1038/sj.onc.1210599 · Cited by 940
Bowers, E. M., Yan, G., Mukherjee, C., Orry, A., Wang, L., Holbert, M. A., Crump, N. T., Hazzalin, C. A., Liszczak, G., Yuan, H., et al. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.03.006 · Cited by 666
Self-citationWriters and Readers of Histone Acetylation: Structure, Mechanism, and Inhibition
Marmorstein, R., & Zhou, M.-M. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a018762 · Cited by 638
Self-citationEpigenetics and cardiovascular disease
Ordovás, J. M., & Smith, C. E. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.104 · Cited by 402
Metadata
- Authors
- Hodawadekar, S. C., & Marmorstein, R.
- Venue
- Oncogene
- Published
- 2007-08-13
- Volume
- 26
- Issue
- 37
- Pages
- 5528-5540
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2081685122
- Cited by
- 272
- References
- 92
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.